Stay updated on Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page.

Latest updates to the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page now displays the batoclimab study record for adults with active CIDP, including its design, eligibility criteria, outcomes, and locations. The record indicates that the study is terminated and is no longer recruiting.SummaryDifference100%

- Check8 days agoChange DetectedThe 403 response was replaced by a largely empty ClinicalTrials.gov study record page, and the site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.6%

- Check15 days agoChange DetectedA sitewide NIH notice announces updates to terminology, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the detailed CIDP study content with a simple error screen and a Home link. The page becomes inaccessible and the usual study information (locations, criteria, and descriptions) is no longer viewable.SummaryDifference21%

Stay in the know with updates to Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Active CIDP: Efficacy & Safety Clinical Trial page.